China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, ...

First-in-class drugs are often considered a signifier of innovation in drug discovery; however, they can also carry substantial uncertainty. A new comparison of approval data for first-in-class drugs ...

Oct. 24, 2024 – The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer.. Marketed under the brand name Vyloy, the drug is to ...

About 2,000 patients are affected by H3 K27M-mutant gliomas annually in the U.S., according to a Chimerix estimate. Dordaviprone is part of a new class of cancer drugs called imipridones.

The FDA’s approval of three new drugs – donanemab, lecanemab and aducanumab – in just over three years has led some to declare a leap forward in Alzheimer’s disease treatment. Japan, South ...

When it comes to drug development, for example, there's a lot more risk associated with developing so called first in class drugs compared to simply making small tweaks over the same kind of old drug.

This is the first new class of treatment for the psychiatric disorder since clozapine, the first atypical antipsychotic, was approved in 1989. Cobenfy is a combination of xanomeline and trospium.

An Astellas Pharma drug designed to address a novel target has landed a highly anticipated FDA approval for a rare type of gastrointestinal cancer, making it the first therapy in a new class of ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller to win FDA approval in more than 20 years.